Dental Anesthesia Market Report 2023 (Global Edition)

Global Dental Anesthesia Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Dental Anesthesia Industry growth. Dental Anesthesia market has been segmented with the help of its Type, Mode of Administration End-User , and others. Dental Anesthesia market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of Dental Anesthesia industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

Dental Anesthesia Market, Type Segment Analysis

• Articaine

The Articaine segment revenue will be USD 209.87 Million by 2028 of Dental Anesthesia Market. Articaine is a safe and effective local anesthetic that can be used on patients of all ages for all standard dental operations. In several nations, it is the most extensively used local anesthetic. During dental treatments, articaine, like other local anesthetics, creates a brief and reversible state of anesthesia (lack of sensation). The FDA authorized it in April of 2000. Articaine is primarily used in dentistry for infiltration injections.

• Lidocaine

Lidocaine is the most common anesthetic used by dentists nowadays. Lidocaine, causes the skin and surrounding tissues to lose feeling. It is used to both prevent and alleviate pain associated with dental treatments. In dentistry, lidocaine is used as a 2% or 5% gel, 2% solution, 4% or 5% solution, 5% ointment, or 10% spray.

• Mepivacaine

Mepivacaine is a numbing drug that works by blocking the nerve impulses that send pain signals to the brain. It is a local anesthetic used for epidural or spinal blocks. It is also used for dental operations as an anesthetic. Mepivacaine is injected into the gum area of the mouth during a dental operation. Mepivacaine can make the patient feel numb for a lengthy time. This medicine should only be administered by or under the supervision of your doctor.

• Prilocaine

Prilocaine has a better clinical performance in terms of giving fast dental anesthetics. A prilocaine injection is used to numb the mouth before undergoing a dental operation. This medicine should only be administered by or under the supervision of the dentist. The solution dosage form of prilocaine is available. It is injected directly into the gums area.

• Bupivacaine

Bupivacaine is a local anesthetic that is used to address a specific area. Dental operations employ bupivacaine as an anesthetic. It is a molecular analog of mepivacaine with high lipid solubility and protein binding properties. When compared to other local anesthetics used in dentistry, these features contribute to bupivacaine's superior potency and anesthetic duration.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Dental Anesthesia Industry. Request a Free Sample PDF!

Dental Anesthesia Market, by Application

The Maxillary segment revenue will be USD 291.29 Million by 2028. The maxillary teeth can be anesthetized by infiltration, regional block, intraligamentary, intra-osseous and intrapulpal anesthesia. Dental anesthesia is produced by a solution deposited on the buccal side of the maxillary alveolus that can permeate through to the pulps of the teeth. This is due to the thinness of the cortical plate on the buccal side of the maxilla. Infiltration anesthesia has the advantage of being a simple procedure that is easy to master, and when successful, it anesthetizes all nerve terminals in the deposition area, regardless of the nerve source

• Mandibular

In dental clinics, mandibular is a common anesthesia route of administration. It is caused by a blockage of the auriculotemporal, inferior alveolar, buccal, mental, incisive, mylohyoid, and lingual nerves. It causes ipsilateral mandibular teeth to be anesthetized up to the midline. Mandibular anesthesia is more difficult to anesthetize than the teeth in the upper jaw (maxillary).

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Dental Anesthesia market report 2023 Edition by contacting our team.

Dental Anesthesia End-User Segment Analysis

• Specialized Dental Hospitals

Specialized Dental Hospitals Revenue in Dental Anesthesia is projected to reach USD 576.02 Million by 2028.

Specialized dental hospitals treated a number of patients on daily basis. This medication is administered as an injection designed to temporarily prevent the teeth’ nerve fibers from transmitting impulses, thereby numbing the area. There is several dental anesthesia are available in the market that should be administered by specialized dental doctors.

• Others

Other facilities such as clinics, hospitals also have dental departments in its place. Dental anesthesia is used by these users to treat the patients.

• Specialized Dental Hospitals
• Others

Dental Anesthesia Market Regional Analysis

Region and country analysis section of Dental Anesthesia Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Dental Anesthesia market.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Dental Anesthesia Industry News

• Pierrel

Pierrel is a global player in the pharmaceutical market. The company provides their products in international market of USA, Canada, Italy, Russia, Poland, Serbia, France, UK, Germany, Kosovo, Austria, Sudan, Taiwan and Indonesia. Products of the company are segmented into anesthesia and prevention. Anesthesia includes articaine, mepivacaine and lidocaine-based anesthetics. Further, the company provides Goccles which helps to see the oral cavity anomalies.

December 2021

Pierrel Announced Highly innovative prototype line for sterile injectable products

The goal of the project is to "analyze, develop, design, and implement a highly innovative prototype line (pilot plant) for the development of sterile liquid injectable dental care drugs and the new Pierrel brand dental anaesthetic molecule, as well as to provide a back-up solution in the event of breakdowns or interruptions to the current production line."

November 2021

Pierrel confirmed the plan's objectives and doubles the capacity

The story from Il sole 24 ore about the plan's aims being confirmed and Pierrel's capacity being doubled. 

• Septodont Holding

Septodont Holding is a France based pharmaceutical and medical device company involved in developing, manufacturing and distributing dental consumables. The products offered by company are dental anesthesia: topical and local anesthetics, safety devices, needles, syringes and reversals and endodontics & restorative products. It also offers regeneration & surgery products.

July 2021

Septodont announced the signing of an agreement for the acquisition of four dental brands from Sanofi.

The acquired portfolio includes Ultracain, a local and infiltrative anesthetic, Rodogyl and Birodogyl, treatments of acute chronic or recurrent stomatological infections, and Dontisolon, an anti-inflammatory, decongestant and analgesic oral paste. This acquisition is helped to improve existing dental portfolio and to strengthen customer base through a broader range of products and solutions.

Top Companies Market Share in Dental Anesthesia Industry: (In no particular order of Rank)

• Septodont
• Dentsply Sirona
• ASPEN Group
• Septodont Holding
• Pierrel
• JohnsonJohnson
• Roche
• Baxter
• Abbott
• Hospira
• Hikma
• AstraZeneca
• Aspen Global Incorporated(AGI)
• Kitron
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..